Document:

EX-10.8

 Exhibit 10.8 
 ENANTA PHARMACEUTICALS, INC. 
 (f/k/a NOVIRX, INC.) 

1995 EQUITY INCENTIVE PLAN 
  

	Section 1.	Purpose 

 The purpose of
the Enanta Pharmaceuticals, Inc. (f/k/a NOVIRx, Inc.) 1995 Equity Incentive Plan (the “Plan”) is to attract and retain key employees and directors and consultants of the Company and its Affiliates, to provide an incentive for them to
achieve long-range performance goals, and to enable them to participate in the long-term growth of the Company. 
  

	Section 2.	Definitions 

“Affiliate” means any business entity in which the Company owns directly or indirectly 50% or more of the total combined voting
power or has a significant financial interest as determined by the Committee. 
 “Award” means any Option, Stock
Appreciation Right, Performance Share, Restricted Stock, Stock Unit or Other Stock-Based Award awarded under the Plan. 

“Board” means the Board of Directors of the Company. 
 “Code” means the Internal Revenue Code of 1986, as amended from time to time, and any successor to such Code. 
 “Committee” means the Board or any committee thereof designated by the Board from time to time as the committee responsible for administering the Plan. 

“Common Stock” or “Stock” means the Common Stock, $0.01 par value, of the Company. 

“Company” means Enanta Pharmaceuticals, Inc., a Delaware corporation. 

“Designated Beneficiary” means the beneficiary designated by a Participant, in a manner determined by the Committee, to receive
amounts due or exercise rights of the Participant in the event of the Participant’s death. In the absence of an effective designation by a Participant, “Designated Beneficiary” shall mean the Participant’s estate. 

“Effective Date” means the date the Plan is approved and adopted by the Board. 

“Fair Market Value” means, with respect to Common Stock or any other property, the fair market value of such property as
determined by the Committee in good faith or in the manner established by the Committee from time to time. 

 “Incentive Stock Option” means an option to purchase shares of Common Stock
awarded to a Participant under Section 6 that is intended to meet the requirements of Section 422 of the Code or any successor provision. 
 “Nonstatutory Stock Option” means an option to purchase shares of Common Stock awarded to a Participant under Section 6 that is not intended to be an Incentive Stock Option. 

“Option” means an Incentive Stock Option or a Nonstatutory Stock Option. 

“Other Stock-Based Award” means an Award, other than an Option, Stock Appreciation Right, Performance Share, Restricted Stock
or Stock Unit, having a Common Stock element and awarded to a Participant under Section 11. 
 “Participant”
means a person selected by the Committee to receive an Award under the Plan. 
 “Performance Cycle” or
“Cycle” means the period of time selected by the Committee during which performance is measured for the purpose of determining the extent to which an award of Performance Shares has been earned. 

“Performance Shares” mean shares of Common Stock, which may be earned by the achievement of performance goals, awarded to a
Participant under Section 8. 
 “Restricted Period” means the period of time during which an Award may be
forfeited to the Company pursuant to the terms and conditions of such Award. 
 “Restricted Stock” means shares of
Common Stock subject to forfeiture awarded to a Participant under Section 9. 
 “Stock Appreciation Right” or
“SAR” means a right to receive any excess in value of shares of Common Stock over the exercise price awarded to a Participant under Section 7. 
 “Stock Unit” means an award of Common Stock or units that are valued in whole or in part by reference to, or otherwise based on, the value of Common Stock, awarded to a Participant under
Section 10. 
  

	Section 3.	Administration 

 The Plan
shall be administered by the Committee. The Committee shall have authority to adopt, alter and repeal such administrative rules, guidelines and practices governing the operation of the Plan as it shall from time to time consider advisable, and to
interpret the provisions of the Plan. The Committee’s decisions shall be final and binding. To the extent permitted by applicable law, the Committee may delegate to one or more executive officers of the Company the power to make Awards to
Participants and all determinations under the Plan with respect thereto, provided that the Committee shall fix the maximum amount of such Awards for all such Participants and a maximum for any one Participant. 

  
 2 

	Section 4.	Eligibility 

 All
employees and, in the case of Awards other than Incentive Stock Options, directors and consultants of the Company or any Affiliate, capable of contributing significantly to the successful performance of the Company, other than a person who has
irrevocably elected not to be eligible, are eligible to be Participants in the Plan. Incentive Stock Options may be awarded only to persons eligible to receive such Options under the Code. 

 

	Section 5.	Stock Available for Awards 

(a) Subject to adjustment under subsection (b), Awards may be made under the Plan for up to 11,950,673 shares of Common Stock. In no event
shall the number of shares of Common Stock that may be subject to Awards for any individual exceed 11,950,673 shares in the aggregate during the term of this Plan, except to the extent of any adjustment under subsection (b). If any Award in respect
of shares of Common Stock expires or is terminated unexercised or is forfeited without the Participant having had the benefits of ownership (other than voting rights), the shares subject to such Award, to the extent of such expiration, termination
or forfeiture, shall again be available for award under the Plan. Common Stock issued through the assumption or substitution of outstanding grants from an acquired company shall not reduce the shares available for Awards under the Plan. Shares
issued under the Plan may consist in whole or in part of authorized but unissued shares or treasury shares. 
 (b) In the event
that the Committee determines that any stock dividend, extraordinary cash dividend, creation of a class of equity securities, recapitalization, reorganization, merger, consolidation, split-up, spin-off, combination, exchange of shares, warrants or
rights offering to purchase Common Stock at a price substantially below fair market value, or other similar transaction affects the Common Stock such that an adjustment is required in order to preserve the benefits or potential benefits intended to
be made available under the Plan, then the Committee (subject, in the case of Incentive Stock Options, to any limitation required under the Code) shall equitably adjust any or all of (i) the number and kind of shares in respect of which Awards
may be made under the Plan, (ii) the number and kind of shares subject to outstanding Awards, and (iii) the award, exercise or conversion price with respect to any of the foregoing, and if considered appropriate, the Committee may make
provision for a cash payment with respect to an outstanding Award, provided that the number of shares subject to any Award shall always be a whole number. 
  

	Section 6.	Stock Options 

 (a)
Subject to the provisions of the Plan, the Committee may award Incentive Stock Options and Nonstatutory Stock Options and determine the number of shares to be covered by each Option, the option price therefor and the conditions and limitations
applicable to the exercise of the Option. The terms and conditions of Incentive Stock Options shall be subject to and comply with Section 422 of the Code or any successor provision and any regulations thereunder. No Incentive Stock Options
shall be granted hereunder after ten years from the last date on which the Plan was approved for purposes of Section 422 of the Code. 

  
 3 

 (b) The Committee shall establish the option price at the time each Option is awarded, which
price shall not be less than 100% of the Fair Market Value of the Common Stock on the date of award with respect to Incentive Stock Options. Nonstatutory Stock Options may be granted at such prices as the Committee may determine. 

(c) Each Option shall be exercisable at such times and subject to such terms and conditions as the Committee may specify in the
applicable Award or thereafter. The Committee may impose such conditions with respect to the exercise of Options, including conditions relating to applicable federal or state securities laws, as it considers necessary or advisable. 

(d) No shares shall be delivered pursuant to any exercise of an Option until payment in full of the option price therefor is received by
the Company. Such payment may be made in whole or in part in cash or, to the extent permitted by the Committee at or after the award of the Option, by delivery of a note or shares of Common Stock owned by the optionee, including Restricted Stock, or
by retaining shares otherwise issuable pursuant to the Option, in each case valued at their Fair Market Value on the date of delivery or retention, or such other lawful consideration as the Committee may determine. 

(e) The Committee may provide that, subject to such conditions as it considers appropriate, upon the delivery or retention of shares to
the Company in payment of an Option, the Participant automatically be awarded an Option for up to the number of shares so delivered. 
  

	Section 7.	Stock Appreciation Rights 

(a) Subject to the provisions of the Plan, the Committee may award SARs in tandem with an Option (at or after the award of the Option), or
alone and unrelated to an Option. SARs in tandem with an Option shall terminate to the extent that the related Option is exercised, and the related Option shall terminate to the extent that the tandem SARs are exercised. SARs granted in tandem with
Options shall have an exercise price not less than the exercise price of the related Option. SARs granted alone and unrelated to an Option may be granted at such exercise prices as the Committee may determine. 

(b) An SAR related to an Option, which SAR can only be exercised upon or during limited periods following a change in control of the
Company, may entitle the Participant to receive an amount based upon the highest price paid or offered for Common Stock in any transaction relating to the change in control or paid during the thirty-day period immediately preceding the occurrence of
the change in control in any transaction reported in the stock market in which the Common Stock is normally traded. 
  

	Section 8.	Performance Shares 

 (a)
Subject to the provisions of the Plan, the Committee may award Performance Shares and determine the number of such shares for each Performance Cycle and the duration of each Performance Cycle. There may be more than one Performance Cycle in
existence at any one time, and the duration of Performance Cycles may differ from each other. The payment value of Performance Shares shall be equal to the Fair Market Value of the Common Stock on the date the Performance Shares are earned or, in
the discretion of the Committee, on the date the Committee determines that the Performance Shares have been earned. 

  
 4 

 (b) The committee shall establish performance goals for each Cycle, for the purpose of
determining the extent to which Performance Shares awarded for such Cycle are earned, on the basis of such criteria and to accomplish such objectives as the Committee may from time to time select. During any Cycle, the Committee may adjust the
performance goals for such Cycle as it deems equitable in recognition of unusual or non-recurring events affecting the Company, changes in applicable tax laws or accounting principles, or such other factors as the Committee may determine.

 (c) As soon as practicable after the end of a Performance Cycle, the Committee shall determine the number of Performance
Shares that have been earned on the basis of performance in relation to the established performance goals. The payment values of earned Performance Shares shall be distributed to the Participant or, if the Participant has died, to the
Participant’s Designated Beneficiary, as soon as practicable thereafter. The Committee shall determine, at or after the time of award, whether payment values will be settled in whole or in part in cash or other property, including Common Stock
or Awards. 
  

	Section 9.	Restricted Stock 

 (a)
Subject to the provisions of the Plan, the Committee may award shares of Restricted Stock and determine the duration of the Restricted Period during which, and the conditions under which, the shares may be forfeited to the Company and the other
terms and conditions of such Awards. Shares of Restricted Stock may be issued for no cash consideration or such minimum consideration as may be required by applicable law. 
 (b) Shares of Restricted Stock may not be sold, assigned, transferred, pledged or otherwise encumbered, except as permitted by the Committee, during the Restricted Period. Shares of Restricted Stock shall
be evidenced in such manner as the Committee may determine. Any certificates issued in respect of shares of Restricted Stock shall be registered in the name of the Participant and unless otherwise determined by the Committee, deposited by the
Participant, together with a stock power endorsed in blank, with the Company. At the expiration of the Restricted Period, the Company shall deliver such certificates to the Participant or if the Participant has died, to the Participant’s
Designated Beneficiary. 
  

	Section 10.	Stock Units 

 (a) Subject
to the provisions of the Plan, the Committee may award Stock Units subject to such terms, restrictions, conditions, performance criteria, vesting requirements and payment rules as the Committee shall determine. 

(b) Shares of Common Stock awarded in connection with a Stock Unit Award shall be issued for no cash consideration or such minimum
consideration as may be required by applicable law. 
  

	Section 11.	Other Stock-Based Awards 

(a) Subject to the provisions of the Plan, the Committee may make other awards of Common Stock and other awards that are valued in whole
or in part by reference to, or are otherwise based on, Common Stock, including without limitation convertible preferred stock, 

  
 5 

 
convertible debentures, exchangeable securities and Common Stock awards or options. Other Stock-Based Awards may be granted either alone or in tandem with other Awards granted under the Plan
and/or cash awards made outside of the Plan. 
 (b) The Committee may establish performance goals, which may be based on
performance goals related to book value, subsidiary performance or such other criteria as the Committee may determine, Restricted Periods, Performance Cycles, conversion prices, maturities and security, if any, for any Other Stock-Based Award. Other
Stock-Based Awards may be sold to Participants at the face value thereof or any discount therefrom or awarded for no consideration or such minimum consideration as may be required by applicable law. 

 

	Section 12.	General Provisions Applicable to Awards 

 (a) Documentation. Each Award under the Plan shall be evidenced by a writing delivered to the Participant specifying the terms and conditions thereof and containing such other terms and conditions
not inconsistent with the provisions of the Plan as the Committee considers necessary or advisable to achieve the purposes of the Plan or to comply with applicable tax and regulatory laws and accounting principles. 

(b) Committee Discretion. Each type of Award may be made alone, in addition to or in relation to any other type of Award. The
terms of each type of Award need not be identical, and the Committee need not treat Participants uniformly. Except as otherwise provided by the Plan or a particular Award, any determination with respect to an Award may be made by the Committee at
the time of award or at any time thereafter. 
 (c) Settlement. The Committee shall determine whether Awards are settled
in whole or in part in cash, Common Stock, other securities of the Company, Awards or other property. The Committee may permit a Participant to defer all or any portion of a payment under the Plan, including the crediting of interest on deferred
amounts denominated in cash and dividend equivalents on amounts denominated in Common Stock. 
 (d) Dividends and Cash
Awards. In the discretion of the Committee, any Award under the Plan may provide the Participant with (i) dividends or dividend equivalents payable currently or deferred with or without interest, and (ii) cash payments in lieu of or in
addition to an Award. 
 (e) Termination of Employment. The Committee shall determine the effect on an Award of the
disability, death, retirement or other termination of employment of a Participant and the extent to which, and the period during which, the Participant’s legal representative, guardian or Designated Beneficiary may receive payment of an Award
or exercise rights thereunder. 
 (f) Change in Control. In order to preserve a Participant’s rights under an Award
in the event of a change in control of the Company, the Committee in its discretion may, at the time an Award is made or at any time thereafter, take one or more of the following actions: (i) provide for the acceleration of any time period
relating to the exercise or realization of the Award, (ii) provide for the purchase of the Award upon the Participant’s request for an amount of cash or other property that could have been received upon the exercise or realization of the
Award had 

  
 6 

 
the Award been currently exercisable or payable, (iii) adjust the terms of the Award in a manner determined by the Committee to reflect the change in control, (iv) cause the Award to be
assumed, or new rights substituted therefor, by another entity, or (v) make such other provision as the Committee may consider equitable and in the best interests of the Company. 

(g) Loans. The Committee may authorize the making of loans or cash payments to Participants in connection with any Award under the
Plan, which loans may be secured by any security, including Common Stock, underlying or related to such Award (provided that such Loan shall not exceed the Fair Market Value of the security subject to such Award), and which may be forgiven upon such
terms and conditions as the Committee may establish at the time of such loan or at any time thereafter. 
 (h) Withholding
Taxes. The Participant shall pay to the Company, or make provision satisfactory to the Committee for payment of, any taxes required by law to be withheld in respect of Awards under the Plan no later than the date of the event creating the tax
liability. In the Committee’s discretion, such tax obligations may be paid in whole or in part in shares of Common Stock, including shares retained from the Award creating the tax obligation, valued at their Fair Market Value on the date of
delivery. The Company and its Affiliates may, to the extent permitted by law, deduct any such tax obligations from any payment of any kind otherwise due to the Participant. 
 (i) Foreign Nationals. Awards may be made to Participants who are foreign nationals or employed outside the United States on such terms and conditions different from those specified in the Plan as
the Committee considers necessary or advisable to achieve the purposes of the Plan or to comply with applicable laws. 
 (j)
Amendment of Award. The Committee may amend, modify or terminate any outstanding Award, including substituting therefor another Award of the same or a different type, changing the date of exercise or realization and converting an Incentive
Stock Option to a Nonstatutory Stock Option, provided that the Participant’s consent to such action shall be required unless the Committee determines that the action, taking into account any related action, would not materially and adversely
affect the Participant. 
  

	Section 13.	Miscellaneous 

 (a) No
Right To Employment. No person shall have any claim or right to be granted an Award, and the grant of an Award shall not be construed as giving a Participant the right to continued employment. The Company expressly reserves the right at any time
to dismiss a Participant free from any liability or claim under the Plan, except as expressly provided in the applicable Award. 

(b) No Rights As Stockholder. Subject to the provisions of the applicable Award, no Participant or Designated Beneficiary shall
have any rights as a stockholder with respect to any shares of Common Stock to be distributed under the Plan until he or she becomes the holder thereof. A Participant to whom Common Stock is awarded shall be considered the holder of the Stock at the
time of the Award except as otherwise provided in the applicable Award. 

  
 7 

 (c) Effective Date. Subject to the approval of the stockholders of the Company, the
Plan shall be effective on the Effective Date. Before such approval, Awards may be made under the Plan expressly subject to such approval. 
 (d) Amendment of Plan. The Board may amend, suspend or terminate the Plan or any portion thereof at any time, subject to any stockholder approval that the Board determines to be necessary or
advisable. 
 (e) Governing Law. The provisions of the Plan shall be governed by and interpreted in accordance with the
laws of the State of Delaware. 
  
  

This Plan was approved by the Board of Directors on July 26, 1995. 
 This Plan was approved by the Stockholders on August 15, 1995. 
 Increase in shares
reserved for issuance under the Plan from 656,557 to 686,088 shares adopted by the Board of Directors December 15, 1999. 
 Increase
in shares reserved for issuance under the Plan from 686,088 to 1,354,243 shares adopted by the Board of Directors April 19, 2000 and approved by the Stockholders on April 28, 2000. 

Increase in shares reserved for issuance under the Plan from 1,354,243 to 2,104,243 shares adopted by the Board of Directors November 3, 2000 and
approved by the Stockholders on November 20, 2000. 
 Increase in shares reserved for issuance under the Plan from 2,104,243 to
2,254,243 shares adopted by the Board of Directors July 25, 2001 and approved by the Stockholders on August 30, 2001. 

Increase in shares reserved for issuance under the Plan from 2,254,243 to 2,302,920 shares adopted by the Board of Directors on October 9, 2001.

 Increase in shares reserved for issuance under the Plan from 2,302,920 to 2,485,670 shares adopted by the Board of Directors on
December 6, 2001. 
 Increase in shares reserved for issuance under the Plan from 2,485,670 to 3,514,757 shares adopted by the Board
of Directors on March 14, 2002. 
 Increases in shares reserved for issuance under the Plan from 2,254,243 to 3,514,757 shares
approved by the Stockholders on June 4, 2002. 
 Increase in shares reserved for issuance under the Plan from 3,514,757 to 4,526,104
shares adopted by the Board of Directors on March 19, 2004. 

  
 8 

 Increase in share reserved for issuance under the Plan from 4,526,104 to 4,544,104 shares adopted by the
Board of Directors on May 7, 2004. 
 Increase in shares reserved for issuance under the Plan from 3,514,757 to 4,544,104 shares
approved by the Stockholders on May 8, 2004. 
 Increase in shares reserved in issuance under the Plan from 4,544,104 to 6,759,526
shares adopted by the Board of Directors on June 9, 2004 and approved by the Stockholders on June 15, 2004. 
 Increase in
shares reserved in issuance under the Plan from 6,759,526 to 7,159,526 shares adopted by the Board of Directors on February 18, 2005 and approved by the Stockholders on May 19, 2005. 

Increase in shares reserved in issuance under the Plan from 7,159,526 to 7,587,973 shares adopted by the Board of Directors on January 24, 2006.

 Increase in shares reserved in issuance under the Plan from 7,587,973 to 7,756,973 shares adopted by the Board of Directors on
August 11, 2006. 
 Increase in shares reserved in issuance under the Plan from 7,159,526 to 7,756,973 shares approved by the
Stockholders on August 17, 2006. 
 Increase in shares reserved in issuance under the Plan from 7,756,973 to 9,327,655 shares
adopted by the Board of Directors on March 28, 2007 and approved by the Stockholders on April 20, 2007. 
 Increase in shares
reserved in issuance under the Plan from 9,327,655 to 9,507,655 shares adopted by the Board of Directors effective as of May 21, 2008, and a further increase from 9,507,655 to 10,207,655 shares adopted by the Board of Directors effective as of
June 10, 2008 and approved by the Stockholders effective as July 8, 2008. 
 Increase in shares reserved in issuance under the
Plan from 10,207,655 to 10,457,655 shares adopted by the Board of Directors on February 4, 2009 and approved by the Stockholders on March 5, 2009. 
 Increase in shares reserved in issuance under the Plan from 10,457,655 to 10,950,673 shares adopted by the Board of Directors on April 29, 2010 and approved by the Stockholders on June 7,
2010. 
 Increase in shares reserved for issuance under the Plan from 10,950,673 to 11,950,673 shares adopted by the Board of Directors
on January 14, 2013 and approved by the Stockholders on January 17, 2013. 

  
 9EX-10.9

 Exhibit 10.9 

 
  
  

			
	Notice of Grant of Stock Options and Option Agreement	  	 Enanta Pharmaceuticals, Inc. ID:

04-3205099
 500 Arsenal Street

Watertown, MA 02472

  
  

 

							
	[Name of Optionholder]	  		  	Option Number:	  	 [-]
	[Address of Optionholder]	  		  	Plan:	  	1995
	[City, State, Postal Code of Optionholder]	  		  		  	

  
  

Effective [-], you have been granted a(n) Incentive Stock Option to buy [-] shares of Enanta Pharmaceuticals, Inc. (the Company) stock at $[-] per share.

 The total option price of the shares granted is $[-]. 
 Shares in each period will become fully vested on the date shown. 
  

															
	Shares	 	 	Vest Type	 	 	Full Vest	 	 	Expiration	 
				
	 	[-]	  	 	 	[-]	  	 	 	[-]	  	 	 	[-]	  

  
  

This option is intended to be treated as an Incentive Stock Option under Section 422 of the Internal Revenue Code of 1986, as amended. This notice,
together with the accompanying Enanta Pharmaceuticals, Inc. 1995 Equity Incentive Plan Incentive Stock Option Terms And Conditions (the Terms and Conditions), as well as the Enanta Pharmaceuticals, Inc. 1995 Equity Incentive Plan (the Plan)
incorporated by reference into the Terms and Conditions, constitute the entire agreement between you and the Company regarding this option. By your signature and the Company’s signature below, you and the Company agree to the terms of this
option, the Terms and Conditions and the Plan. 
  
  

 

					
	  
	 		 	  

	Enanta Pharmaceuticals, Inc.	 		 	Date
			
	  
	 		 	  

			
	[Name of Optionholder]	 		 	Date

  

							
		 		 		  	 Date: [-]
 Time:
[-]

 ENANTA PHARMACEUTICALS, INC. 

1995 EQUITY INCENTIVE PLAN 
 Incentive Stock Option Terms And Conditions 

 

 1. Plan Incorporated by Reference. This Option is issued pursuant to the terms of
the Plan and may be amended as provided in the Plan. Capitalized terms used and not otherwise defined in this certificate have the meanings given to them in the Plan. This certificate does not set forth all of the terms and conditions of the Plan,
which are incorporated herein by reference. The Committee administers the Plan and its determinations regarding the operation of the Plan are final and binding. Copies of the Plan may be obtained upon written request without charge from the Company.

 2. Option Price. The price to be paid for each share of Common Stock issued upon exercise of the whole or any part
of this Option is the Option Price set forth on the face of this certificate. 
 3. Exercisability Schedule. This
Option may be exercised at any time and from time to time for the number of shares and in accordance with the exercisability schedule set forth on the face of this certificate, but only for the purchase of whole shares. This Option may not be
exercised as to any shares after the Expiration Date. 
 4. Method of Exercise. To exercise this Option, the
Optionholder shall deliver written notice of exercise to the Company specifying the number of shares with respect to which the Option is being exercised accompanied by payment of the Option Price for such shares in cash, by certified check or in
such other form, including shares of Common Stock of the Company valued at their Fair Market Value on the date of delivery, as the Committee may approve. Promptly following such notice, the Company will deliver to the Optionholder a certificate
representing the number of shares with respect to which the Option is being exercised. 
 5. Rights as a Stockholder or
Employee. The Optionholder shall not have any rights in respect of shares as to which the Option shall not have been exercised and payment made as provided above. The Optionholder shall not have any rights to continued employment by the Company
or its Affiliates by virtue of the grant of this Option. 
 6. Recapitalization, Mergers, Etc. As provided in the Plan,
in the event of corporate transactions affecting the Company’s outstanding Common Stock, the Committee shall equitably adjust the number and kind of shares subject to this Option and the exercise price hereunder or make provision for a cash
payment. If such transaction involves a consolidation or merger of the Company with another entity, the sale or exchange of all or substantially all of the assets of the Company or a reorganization or liquidation of the Company, then in lieu of the
foregoing, the Committee may upon written notice to the Optionholder provide that this Option shall terminate on a date not less than 20 days after the date of such notice unless theretofore exercised. In connection with such notice, the Committee
may in its discretion accelerate or waive any deferred exercise period. 
 7. Option Not Transferable. This Option is
not transferable by the Optionholder otherwise than by will or the laws of descent and distribution, and is exercisable, during the

 
Optionholder’s lifetime, only by the Optionholder. The naming of a Designated Beneficiary does not constitute a transfer. 

8. Exercise of Option After Termination of Employment. If the Optionholder’s employment with (a) the Company,
(b) an Affiliate, or (c) a corporation (or parent or subsidiary corporation of such corporation) issuing or assuming a stock option in a transaction to which section 424(a) of the Code applies, is terminated for any reason other than by
disability (within the meaning of section 22(e)(3) of the Code) or death, the Optionholder may exercise the rights which were available to the Optionholder at the time of such termination only within three months from the date of termination. If
Optionholder’s employment is terminated as a result of disability, such rights may be exercised within twelve months from the date of termination. Upon the death of the Optionholder, his or her Designated Beneficiary shall have the right, at
any time within twelve months after the date of death, to exercise in whole or in part any rights that were available to the Optionholder at the time of death. Notwithstanding the foregoing, no rights under this Option may be exercised after the
Expiration Date. 
 9. Compliance with Securities Laws. It shall be a condition to the Optionholder’s right to
purchase shares of Common Stock hereunder that the Company may, in its discretion, require (a) that the shares of Common Stock reserved for issue upon the exercise of this Option shall have been duly listed, upon official notice of issuance,
upon any national securities exchange or automated quotation system on which the Company’s Common Stock may then be listed or quoted, (b) that either (i) a registration statement under the Securities Act of 1933 with respect to the
shares shall be in effect, or (ii) in the opinion of counsel for the Company, the proposed purchase shall be exempt from registration under that Act and the Optionholder shall have made such undertakings and agreements with the Company as the
Company may reasonably require, and (c) that such other steps, if any, as counsel for the Company shall consider necessary to comply with any law applicable to the issue of such shares by the Company shall have been taken by the Company or the
Optionholder, or both. The certificates representing the shares purchased under this Option may contain such legends as counsel for the Company shall consider necessary to comply with any applicable law. 

10. Payment of Taxes. The Optionholder shall pay to the Company, or make provision satisfactory to the Company for payment of,
any taxes required by law to be withheld with respect to the exercise of this Option. The Committee may, in its discretion, require any other Federal or state taxes imposed on the sale of the shares to be paid by the Optionholder. In the
Committee’s discretion, such tax obligations may be paid in whole or in part in shares of Common Stock, including shares retained from the exercise of this Option, valued at their Fair Market Value on the date of delivery. The Company and its
Affiliates may, to the extent permitted by law, deduct any such tax obligations from any payment of any kind otherwise due to the Optionholder. 
 11. Notice of Sale of Shares Required. The Optionholder agrees to notify the Company in writing within 30 days of the disposition of any shares purchased upon exercise of this Option if such
disposition occurs within two years of the date of the grant of this Option or within one year after such purchase

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00213-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00213-of-00352.parquet"}]]